1.
Bioorg Med Chem Lett
; 17(23): 6525-8, 2007 Dec 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-17936624
RESUMEN
We describe three novel regioisomeric series of aryl naphthyridine analogs, which are potent antagonists of the Class III GPCR mGlu5 receptor. The synthesis and in vitro and in vivo pharmacological activities of these analogs are discussed.